Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Tarsus Pharmaceuticals Inc
TARSCurrent price
33.26 USD
+1.56 USD (+4.92%)
Last closed
31.7 USD
Company
www.tarsusrx.com
ISIN
US87650L1035
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 163 695 616 USD
Yield for 12 month
+100.97 %
1Y
3Y
5Y
10Y
15Y
TARS
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California. Address: 15440 Laguna Canyon Road, Irvine, CA, United States, 92618
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
58.5 USDP/E ratio
–Dividend Yield
–Current Year
+17 447 000 USD
Last Year
+25 816 000 USD
Current Quarter
+40 813 000 USD
Last Quarter
+27 614 000 USD
Current Year
+15 854 000 USD
Last Year
+24 861 000 USD
Current Quarter
+37 809 000 USD
Last Quarter
+25 960 000 USD
Key Figures TARS
1 year
3 years
5 years
10 years
EBITDA
-155 271 008 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-34.55 %
PEG Ratio
–
Return On Equity TTM
-75.04 %
Wall Street Target Price
58.5 USD
Revenue TTM
83 374 000 USD
Book Value
6.63 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
1004.6 %
Dividend Yield
–
Gross Profit TTM
-17 763 000 USD
Earnings per share
-4.46 USD
Diluted Eps TTM
-4.46 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-180 %
Dividend Analytics TARS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TARS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation TARS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
10.9194
Price Sales TTM
13.9575
Enterprise Value EBITDA
-3.232
Price Book MRQ
4.6058
Financials TARS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TARS
For 52 weeks
12.57 USD
42.5 USD
50 Day MA
26.6 USD
Shares Short Prior Month
9 758 485
200 Day MA
28.49 USD
Short Ratio
10.84
Shares Short
9 541 360
Short Percent
26 %
BeatStart